Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes

被引:56
作者
Fujita, M
Enomoto, T
Murata, Y
机构
[1] Osaka Univ, Fac Med, Dept Obstet & Gynecol, Suita, Osaka 565, Japan
[2] Osaka Rosai Hosp, Dept Obstet & Gynecol, Osaka, Japan
关键词
ovary; oncogene; tumor suppressor gene; histology; tumor;
D O I
10.1016/S0303-7207(03)00069-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multiple genetic changes including activation of proto-oncogenes and inactivation of tumor suppressor gene are involved in the development of human ovarian cancer. We describe such genetic alterations with specific reference to histological subtypes. K-ras activation is specific for mucinous tumors including adenomas. Borderline tumors and carcinomas, suggesting that K-ras activation may be associated with the mucinous differentiation rather than malignant transformation. Inactivation of p53 is detected in 30-40% of ovarian carcinoma. Mutations are more frequently observed in serous carcinomas, but not found in adenomas or rarely found in borderline tumors, suggesting that p53 mutations may be directly involved in malignant transformation. TGFbeta-2 mutations are found in 50% of endometrioid carcinoma, but rarely in other type. Loss of DCC mRNA expression is found in 50% of serous carcinomas but less frequently in other type. Loss of DCC expression is rare in borderline tumors and adenomas, suggesting that inactivation of DCC may be directly involved in malignant transformation. Microsatellite instability (MI) is found in 17% of ovarian carcinomas, and is frequently found in endometrioid carcinomas. Although inactivation of p16 by point mutation or deletion is rare, p16 inactivation by loss of expression is relatively common. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 99
页数:3
相关论文
共 12 条
[1]  
ENOMOTO T, 1991, AM J PATHOL, V139, P777
[2]  
ENOMOTO T, 1990, CANCER RES, V50, P6139
[3]   LOSS OF EXPRESSION AND LOSS OF HETEROZYGOSITY IN THE DCC GENE IN NEOPLASMS OF THE HUMAN FEMALE REPRODUCTIVE-TRACT [J].
ENOMOTO, T ;
FUJITA, M ;
CHENG, C ;
NAKASHIMA, R ;
OZAKI, M ;
INOUE, M ;
NOMURA, T .
BRITISH JOURNAL OF CANCER, 1995, 71 (03) :462-467
[4]  
Fujita M, 1997, INT J CANCER, V74, P148, DOI 10.1002/(SICI)1097-0215(19970422)74:2<148::AID-IJC2>3.3.CO
[5]  
2-9
[6]   ALTERATION OF THE P53 TUMOR-SUPPRESSOR GENE OCCURS INDEPENDENTLY OF K-RAS ACTIVATION AND MORE FREQUENTLY IN SEROUS ADENOCARCINOMAS THAN IN OTHER COMMON EPITHELIAL TUMORS OF THE HUMAN OVARY [J].
FUJITA, M ;
ENOMOTO, T ;
INOUE, M ;
TANIZAWA, O ;
OZAKI, M ;
RICE, JM ;
NOMURA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (12) :1247-1256
[7]   Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer [J].
Fujita, M ;
Enomoto, T ;
Yoshino, K ;
Nomura, T ;
Buzard, GS ;
Inoue, M ;
Okudaira, Y .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) :361-366
[8]  
Lynch MA, 1998, CANCER RES, V58, P4227
[9]   P53 EXPRESSION, MUTATION, AND ALLELIC DELETION IN OVARIAN-CANCER [J].
MCMANUS, DT ;
YAP, EPH ;
MAXWELL, P ;
RUSSELL, SEH ;
TONER, PG ;
MCGEE, JO .
JOURNAL OF PATHOLOGY, 1994, 174 (03) :159-168
[10]  
MILNER BJ, 1993, CANCER RES, V53, P2128